伤科接骨片与芬必得治疗颈椎病的临床疗效对比

A clinical comparison of therapeutic effects of“SHANGKE JIEGU PIAN”and Fenbid in the treatment of cervical spondylosis

采用单盲随机分组法，以伤科接骨片为治疗组，芬必得为对照组，共治疗气滞血瘀型及痰湿阻络、郁热内结型颈椎病１０４例。结果发现治疗组近期（治疗２周）和远期（治疗后２个月）总有效率均好于对照组；近期和远期治愈率相比有统计学差异（Ｐ＜０．０５）；且治疗组远期疗效积分值降低度明显优于对照组（Ｐ＜０．０１）。经年龄分层和中医辨证分型后发现，两种药物均适于各种年龄层患者，但伤科接骨片对痰湿阻络、郁热内结型颈椎病患者有较好的疗效（Ｐ＜０．０５）。这提示伤科接骨片较芬必得治疗颈椎病有疗效确切（特别是对痰湿阻络、郁热内结型）、复发率低等优点。

One hundred and four cases of cervical spondylosis were blindly and randomly grouped into the treated and control groups,which were treated by “SHANGKE JIEGU PIAN”(SKJGP) (Tablets for Fracture Healing) and Fenbid,respectively.All the cases included three types:Qi stagnancy and blood stasis (QSBS),phlegm dampness stagnation(PDS)and stagnated heat accumulation (SHA).The results showed that:1.both shortterm(2 weeks after treatment)and long term(2 months after treatment)total effective rates of the treated group were better than those of the control;2.the short term and long term curative rates of the two groups had a statistical difference(P<0 05);3.the reduction of the integrated values of the long term results of the treated group had a significant advantage over that of the control (P<0 01).Through age grouping and TCM syndromes differentiating,it was found that both of the drugs were suitable for the patients of all age groups,but SKJGP could produce better results for PDS and SHA types (P<0 05),suggesting that in the treatment of cervical spondylosis,SKJGP could have more definite results and lower recurrent rate than Fenbid.